Skip to main content
Clinical Trials/NCT06234254
NCT06234254
Not yet recruiting
Not Applicable

Reducing Adult Inpatients Anxiety With Virtual Reality Meditation: A Prospective, Randomized Study

Stanford University1 site in 1 country200 target enrollmentJune 1, 2026

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anxiety
Sponsor
Stanford University
Enrollment
200
Locations
1
Primary Endpoint
Hospital Anxiety and Depression Scale (HADS)
Status
Not yet recruiting
Last Updated
11 months ago

Overview

Brief Summary

The purpose of the study is to evaluate if non-invasive, distracting devices (virtual reality) can decrease anxiety and improve affect and satisfaction in adult, hospitalized patients.

Registry
clinicaltrials.gov
Start Date
June 1, 2026
End Date
May 31, 2027
Last Updated
11 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Thomas Caruso

Clinical Professor

Stanford University

Eligibility Criteria

Inclusion Criteria

  • between age 18-99
  • hospitalized at Stanford Health Care
  • english-speaking

Exclusion Criteria

  • significant cognitive impairment or inability to consent
  • current nausea
  • visual problems or currently using corrective glasses that are incompatible with the virtual reality headset
  • a history of severe motion sickness
  • a history of seizures cause by flashing light
  • clinically unstable or require immediate/urgent intervention

Outcomes

Primary Outcomes

Hospital Anxiety and Depression Scale (HADS)

Time Frame: Before and Immediate after intervention

Hospital Anxiety and Depression Scale (HADS) questionnaire. The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. The anxiety and depression subscales each range from 0 to 21, with higher scores indicating higher anxiety/depression complains. Patients were defined as having anxiety or depression or both if the score was 8 or more in the corresponding subscale.

Study Sites (1)

Loading locations...

Similar Trials